26 research outputs found

    Journal of Advances in Medical and Pharmaceutical Sciences

    Get PDF
    Aim: To evaluate the effects of graded doses of ethanolic stem bark extract of Picralima nitida on haematological profile, some serum reproductive hormones, sperm reserves and testicular histomorphology of male albino rats. Study Design: Thirty male albino rats, weighing between 120 and 200 grams were randomly assigned into six groups of five rats each. Group A received 0.5 ml of distilled water (normal control). Groups B, C and D received 100, 200 and 400 mg/kg BW of the extract respectively. Group E received 2.5 mg/kg BW of CdCl2 (negative control), while Group F received 5 mg/kg BW of Sildenafil (positive control); orally every other day for six weeks. Place and Duration of Study: Department of Veterinary Physiology and Pharmacology (Laboratory Animal Unit), University of Nigeria, Nsukka, between June and September, 2015. Methodology: At the end of the experiment, blood samples were collected for haematology and serology, whereas testicular sections were collected for histopathology following the standards procedures. Data obtained were analyzed by One-way ANOVA. Results: The result showed that all doses of the extract increased neutrophil count, but decreased (P < 0.05) monocyte and RBC counts; 200 and 400 mg/kg BW of the extract decreased (P < 0.05) PCV values; and only 400 mg/kg of the extract reduced (P < 0.05) HB values. 200 and 400 mg/kg BW of the extract, and 2.5 mg/kg BW of CdCl2 decreased (P < 0.05) serum testosterone and sperm counts. The normal control, 100 mg/kg BW of the extract and 5 mg/kg BW of Sildenafil had normal testicular histoarchitecture; whereas 200 and 400 mg/kg BW of the extract, and 2.5 mg/kg BW of CdCl2 had slight, moderate and severe degeneration of the germinal epithelium and interstitium, with depletion of sperm cells in the lumen of the seminiferous tubules respectively. Conclusion: This study revealed that treatment with ethanolic stem bark extract of Picralima nitida above 100 mg/kg BW adversely affected haematological and reproductive parameters in male albino rats

    Stigma, medication adherence and coping mechanism among people living with HIV attending General Hospital, Lagos Island, Nigeria

    No full text
    Background: People living with HIV and AIDS (PLWHA) experience some form of stigma which could lead to poor medication adherence.Objectives: This study assessed the various domains of stigma experienced by PLWHAs attending an HIV clinic at General Hospital, Lagos Island, their medication adherence patterns and their coping mechanisms for ensuring adherence to antiretroviral therapy.Method: A cross-sectional study design with a sample size of 200 was used. Respondents were selected using systematic random sampling. Interviewers administered structured questionnaires were used to collect information on the domains of stigma. Data was analysedusing EPI info©. This was followed by a focus group discussion (FGD) with seven participants at the clinic using an interview guide with open-ended questions.Results: Overall, stigma was experienced by 35% of the respondents. Within this group, 6.6%, 37.1%, 43.1% and 98.0% of the respondents reported experiencing negative self image stigma, personalised stigma, disclosure stigma and public attitude stigma respectively. Almost 90% of the respondents were adherent. The FGD revealed that disclosure was usually confined to family members and the coping mechanism for achieving adherence was to put antiretroviral (ARVs) in unlabelled pill boxes.Conclusion: This study found that stigma was low and that the most common domain of stigma experienced was public attitude stigma. Medication adherence of respondents was good as a result of the coping mechanism, which involves putting ARVs in unlabelled pill boxes

    Attitudes Toward Genomic Testing And Prostate Cancer Research Among Black Men

    No full text
    Introduction: Black men are diagnosed with prostate cancer at nearly twice the rate of white men and are underrepresented in prostate cancer research, including validation studies of new clinical tools (e.g., genomic testing). Because healthcare system mistrust has contributed to these disparities for centuries, black men may be less inclined to pursue novel testing, and identification of facilitators to their participation in prostate cancer research studies remains warranted. Methods: A community-engaged approach involving a partnership with a community organization was used to conduct seven focus groups in Minnesota, Alabama, and California to explore black men\u27s attitudes toward prostate cancer research participation and genomic testing for prostate cancer. Data were collected and analyzed from April 2015 to April 2017. Results: Identified genomic testing barriers included a lack of terminology understanding, healthcare system mistrust, reluctance to seek medical care, and unfavorable attitudes toward research. Facilitators included family history, value of prevention, and the desire for health education. Lack of prostate cancer knowledge, prostate-specific antigen testing confusion, healthcare system distrust, and misuse of personal health information were barriers to research study participation. Some black men were motivated to participate in research if it was seen as constructive and transparent. Conclusions: Disparities for black men can both motivate and disincentivize participation depending upon a positive or negative view of research. Confusion over prostate cancer clinical care has fueled some mistrust among black men affecting both clinical care and research participation. With increased education, health literacy, and assurances of research integrity and transparency, black men may be more willing to participate in prostate cancer testing and research. Supplement information: This article is part of a supplement entitled African American Men\u27s Health: Research, Practice, and Policy Implications, which is sponsored by the National Institutes of Health
    corecore